Challenges in Using Circulating miRNAs as Cancer BiomarkersPaola Tiberio, Valentina Appierto, Maurizio Callari et al.|BioMed Research International|2015Cited by 264
miR-21: an oncomir on strike in prostate cancerMarco Folini, Nadia Zaffaroni, Paolo Gandellini et al.|Molecular Cancer|2010Cited by 226
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug responseDimitra Georgopoulou, Shelley Harris, Fatime Qosaj et al.|Nature Communications|2021Cited by 59
Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast CancerAbigail Shea, Alejandra Bruna, Yaniv Lubling et al.|Cancer Research|2024Cited by 7
Data from Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast CancerAbigail Shea, Alejandra Bruna, Yaniv Lubling et al.|Unknown|2025Cited by 1